Tag Archives: Chris Wagner

Emerald Health Northern Vine Labs

Emerald Health Announces No Material Change

Emerald Health Announces No Material Change

VICTORIA, British Columbia, Dec. 13, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (the “Company”) is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity of its stock.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine

VICTORIA, British Columbia, Oct. 26, 2017 /Weed Wire/ – Emerald Health Therapeutics Inc. (“Emerald”) (EMH.V) (EMHTF) announced today that it has signed a definitive agreement (the “Agreement”) with Northern Vine Canada Inc. (“Northern Vine”) and Abattis Bioceuticals Corp. (“Abattis”) (CSE:ATT) (ATTBF) to invest $2.5 million into Northern Vine to acquire 53% of the company and appoint three of its four directors. Abattis will continue to hold the remaining 47% of Northern Vine.


Top